Gossamer Bio, Inc. (GOSS)

0.3473 -1.78 (-83.69%) USD  |  NASDAQ  |  Feb 23, 12:32
More

Gossamer Bio Stock Based Compensation (Quarterly)

Stock Based Compensation (Quarterly) Chart

View Stock Based Compensation (Quarterly) for GOSS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Quarterly) Range, Past 5 Years

View Stock Based Compensation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Quarterly) Benchmarks

View Stock Based Compensation (Quarterly) Benchmarks
Start Trial
Madrigal Pharmaceuticals, Inc. Upgrade
XOMA Royalty Corp. Upgrade
Rezolute, Inc. Upgrade
Axsome Therapeutics, Inc. Upgrade
Crinetics Pharmaceuticals, Inc. Upgrade